CAMBRIDGE, MA – American biotech company Moderna says its Coronavirus vaccine is nearly 95-percent effective.
The company released its early clinical trial data on Monday morning.
Moderna plans to seek FDA authorization for the immunization after more safety data is gathered later this month.
Of the 15,000 participants who received the vaccine, only five contracted COVID-19 and none became seriously ill.
It’s the second vaccine in the united states to have a stunningly high success rate.
Last week, Pfizer announced that early data shows its vaccine is more than 90-percent effective against the virus.
The nation’s top infectious disease expert Doctor Anthony Fauci says COVID-19 vaccinations could start as soon as mid-December.
It’s expected that high-risk groups like health care workers, the elderly, and people with underlying medical conditions would get the vaccine first.
It could be available to everyone else by spring.